Patents by Inventor William Olson

William Olson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200148751
    Abstract: The present invention provides monoclonal antibodies, or antigen-binding fragments thereof, that bind to Ebola virus glycoproteins, pharmaceutical compositions comprising the antibodies and methods of use. The antibodies of the invention are useful for inhibiting or neutralizing Ebola virus activity, thus providing a means of treating or preventing Ebola virus infection in humans. In some embodiments, the invention provides for use of one or more antibodies that bind to the Ebola virus for preventing viral attachment and/or entry into host cells. The antibodies of the invention may be used prophylactically or therapeutically and may be used alone or in combination with one or more other anti-viral agents or vaccines.
    Type: Application
    Filed: October 24, 2019
    Publication date: May 14, 2020
    Inventors: Christos Kyratsous, William Olson, Peter Mason, Neil Stahl
  • Patent number: 10633434
    Abstract: The present invention provides monoclonal antibodies that bind to the complement factor 5 (C5) protein, and methods of use thereof. In various embodiments of the invention, the antibodies are fully human antibodies that bind to C5 protein. In some embodiments, the antibodies of the invention are useful for inhibiting or neutralizing C5 activity, thus providing a means of treating or preventing a C5-related disease or disorder in humans. In some embodiments, the invention provides for an anti-C5 antibody that has improved pharmacokinetic and pharmacodynamic properties, e.g., a half-life of more than 10 days.
    Type: Grant
    Filed: June 13, 2017
    Date of Patent: April 28, 2020
    Assignee: Regeneron Pharmaceuticals, Inc.
    Inventors: Ying Hu, Adrianna Latuszek, Carmelo Romano, William Olson
  • Publication number: 20200121125
    Abstract: A flexible robotic kitchen assistant automates the preparation of food items. The robotic kitchen assistant includes a robotic arm, a sensor assembly comprising a plurality of cameras aimed at a kitchen workspace for preparing the food items, a controller operable to move the robotic arm, and a processor. The processor is operable to command the robotic arm to perform a food preparation step on the food items in the kitchen workspace based on order information, recipe information, kitchen equipment information, and camera data. The system is capable of performing a wide range of tasks commonly used in residential and commercial kitchens and is able to work collaboratively with and in close proximity to human kitchen workers.
    Type: Application
    Filed: March 6, 2018
    Publication date: April 23, 2020
    Applicant: Miso Robotics, Inc.
    Inventors: David Zito, Sean Olson, Ryan W. Sinnet, Robert Anderson, Benjamin Pelletier, Grant Stafford, Zachary Zweig Vinegar, William Werst
  • Patent number: 10608452
    Abstract: A charging stand is provided including a body having a first surface, and a bump having a top region and one or more sides. The one or more sides extend between the first surface and the top region. The charging stand further includes one or more base contact pins that are coupled to the body. Each base contact pin has an exposed end disposed at a first distance in a first direction from the first surface. The charging stand further includes a bump contact pin extending from the top region of the bump. The bump contact pin has an exposed end disposed a second distance in the first direction from the first surface, the second distance is greater than the first distance, and the first direction is perpendicular to the first surface.
    Type: Grant
    Filed: January 28, 2019
    Date of Patent: March 31, 2020
    Assignee: LOGITECH EUROPE, S.A.
    Inventors: Alan Olson, William Christopher Carmichael, Dominic Amae, Alexander S. Danielson, Donald Robert Mayette, Steven Ryutaro Takayama, Branko Lukic, Kevin Kilpatrick, Patrick Nicolet, Gabriel Antonio Ulloa
  • Publication number: 20200086154
    Abstract: A pump panel training device is provided and includes a plurality of simulated gages operable to imitate gages upon a fire truck pump panel, a plurality of simulated controls operable to imitate controls upon the fire truck pump panel, and a simulated water hose operable to imitate one of water temperature changes, water temperature pressure, and water hose vibration for the fire truck pump panel.
    Type: Application
    Filed: September 13, 2019
    Publication date: March 19, 2020
    Inventors: David S. Bouwkamp, William Martin, Nikolaos Dimitri Zachary Kazakos, James R. Mason, Dale Eammon Atkin, Travis Staley, Steven Olson, Joseph Lewis Clift, Stuart Ball, Philip C. Duczyminski
  • Publication number: 20200062831
    Abstract: The present invention provides monoclonal antibodies, or antigen-binding fragments thereof, that bind to ZIKV glycoproteins, pharmaceutical compositions comprising the antibodies and methods of use. The antibodies of the invention are useful for inhibiting or neutralizing ZIKV activity, thus providing a means of treating or preventing ZIKV infection in humans. In some embodiments, the invention provides for use of one or more antibodies that bind to the ZIKV for preventing viral attachment and/or entry into host cells. The antibodies of the invention may be used prophylactically or therapeutically and may be used alone or in combination with one or more other anti-viral agents or vaccines.
    Type: Application
    Filed: August 9, 2019
    Publication date: February 27, 2020
    Inventors: Christos Kyratsous, William Olson, Peter Mason
  • Patent number: 10544962
    Abstract: A storage-type water heater including a tank for supporting water to be heated, a first heating element, a first relay connected to the first heating element, a second heating element, a second relay connected to the second heating element, and a controller for selectively operating the first relay and the second relay. The controller includes instructions for selecting a mode from at least, a no-sequencing mode, wherein the first relay and the second relay are operated concurrently, and a sequencing mode, wherein the first relay and the second relay are operated sequentially. The controller also operates the first relay to supply power to the first heating element, and operates the second relay to supply power to the second heating element, based on the selected mode.
    Type: Grant
    Filed: August 10, 2016
    Date of Patent: January 28, 2020
    Assignee: AOS HOLDING COMPANY
    Inventors: Andrew Robert Caves, Andrew William Phillips, Brian Thomas Branecky, William Louis Mehlhorn, Thomas G. Van Sistine, Robert Eugene Olson, Zhongsheng Niu
  • Patent number: 10540551
    Abstract: Methods, systems, and computer programs are presented for capturing color images of items for a machine-learning model. In one method, a request, for adding an item to be visually recognized during sales transactions, is detected at a checkout apparatus. Further, the method includes capturing and storing a color image, by each of one or more cameras of the checkout apparatus, of an examination space when the item is present. Further, the capturing and storing of color images of the item is repeated at different poses until at a predetermined number of color images of the item are captured. Further, the method includes generating, by a processor of the checkout apparatus, additional images of the item by modifying the captured color images. A machine-learning model for item recognition is built by training a machine-learning tool with the captured images and the additional images.
    Type: Grant
    Filed: November 5, 2018
    Date of Patent: January 21, 2020
    Assignee: Mashgin Inc.
    Inventors: Abhinai Srivastava, Mukul Dhankhar, Yong Li, Maxwell William Olson
  • Publication number: 20200017592
    Abstract: The present invention provides antibodies and antigen-binding fragments (e.g., human E antibodies) that bind specifically to human IL-36 receptor. Methods for treating or preventing diseases mediated by IL36R (e.g., skin or colon inflammatory conditions such as palmo-plantar pustular psoriasis, palmoplantar pustulosis, generalized pustular psoriasis, ulcerative colitis or IBD) using the antibodies and fragments are also provided along with methods of making the antibodies and fragments.
    Type: Application
    Filed: July 16, 2019
    Publication date: January 16, 2020
    Inventors: Jeanette Fairhurst, Elena Garnova, William Olson
  • Publication number: 20200016275
    Abstract: The present invention provides antibodies that bind to Staphylococcus aureus Hemolysin A toxin, and methods of use. According to certain embodiments of the invention, the antibodies are fully human antibodies that bind to Hemolysin A. The antibodies of the invention are useful for inhibiting or neutralizing Hemolysin A activity, thus providing a means of preventing or treating a Hemolysin A-related disease or disorder such as S. aureus infection. In some embodiments, the antibodies of the present invention are used in treating at least one symptom or complication of a S. aureus infection.
    Type: Application
    Filed: September 19, 2019
    Publication date: January 16, 2020
    Inventors: ALIDA COPPI, PETER MASON, WILLIAM OLSON
  • Publication number: 20200017576
    Abstract: The present invention provides monoclonal antibodies, or antigen-binding fragments thereof, that bind to the influenza hemagglutinin (HA) protein, pharmaceutical compositions comprising the antibodies and methods of use. The antibodies of the invention are useful for inhibiting or neutralizing influenza virus activity, thus providing a means of treating or preventing influenza infection in humans. In some embodiments, the invention provides for use of one or more antibodies that bind to the influenza HA for preventing viral attachment and/or entry into host cells. The antibodies of the invention may be used prophylactically or therapeutically and may be used alone or in combination with one or more other anti-viral agents or vaccines.
    Type: Application
    Filed: July 25, 2019
    Publication date: January 16, 2020
    Inventors: Lisa A. Purcell, Jonathan Viau, William Olson
  • Publication number: 20190389571
    Abstract: A tiltrotor aircraft includes a propulsion system with a fixed engine and a rotatable proprotor. The engine is located below the wing of the tiltrotor aircraft, and the rotatable proprotor assembly is mounted on the top surface of the wing. The engine and proprotor assembly are connected via a series of one or more gearboxes that route the engine output from the engine to the proprotor.
    Type: Application
    Filed: June 21, 2018
    Publication date: December 26, 2019
    Applicant: Bell Helicopter Textron Inc.
    Inventors: Colton Gilliland, Jeffrey Williams, Michael E. Rinehart, James Kooiman, Mark Przybyla, Clegg Smith, Eric Stephen Olson, George Ryan Decker, David Russell Bockmiller
  • Publication number: 20190389572
    Abstract: A tiltrotor aircraft includes a propulsion system with a fixed engine and a rotatable proprotor. The engine is located on the top surface of the wing of the tiltrotor aircraft, and the rotatable proprotor assembly is also mounted on the top surface of the wing. The engine and proprotor assembly are connected via a series of one or more gearboxes that route the engine output from the engine to the proprotor.
    Type: Application
    Filed: June 22, 2018
    Publication date: December 26, 2019
    Applicant: Bell Helicopter Textron Inc.
    Inventors: Colton Gilliland, Jeffrey Williams, Michael E. Rinehart, James Kooiman, Mark Przybyla, Clegg Smith, Eric Stephen Olson, George Ryan Decker, David Russell Bockmiller
  • Publication number: 20190388990
    Abstract: A power delivery system includes a power-input-channel, an AC/DC converter, one or more controller-circuits, a silicon-controlled-rectifier, a transformer, and a pair of output-leads. The power-input-channel receives alternating-current from a power-source. The AC/DC converter converts the alternating-current to a direct-current at a converter-output. The one or more controller-circuits are connected with the converter-output and control a signal indicative of a desired-power-level delivered for a desired-time. The silicon-controlled-rectifier is connected with the power-input-channel and controls an SCR-output-voltage to an SCR-output-channel proportional to the signal. The transformer reduces the SCR-output-voltage from a primary-side to a secondary-voltage on a secondary-side. The pair of output-leads are connected with poles of the secondary-side. A solder-joint is disposed between the pair of output-leads.
    Type: Application
    Filed: June 20, 2018
    Publication date: December 26, 2019
    Inventors: Gordon Olson, Michael E. Wheaton, William Falk
  • Patent number: 10501526
    Abstract: The present invention provides monoclonal antibodies, or antigen-binding fragments thereof, that bind to Ebola virus glycoproteins, pharmaceutical compositions comprising the antibodies and methods of use. The antibodies of the invention are useful for inhibiting or neutralizing Ebola virus activity, thus providing a means of treating or preventing Ebola virus infection in humans. In some embodiments, the invention provides for use of one or more antibodies that bind to the Ebola virus for preventing viral attachment and/or entry into host cells. The antibodies of the invention may be used prophylactically or therapeutically and may be used alone or in combination with one or more other anti-viral agents or vaccines.
    Type: Grant
    Filed: August 22, 2018
    Date of Patent: December 10, 2019
    Assignee: REGENERON PHARMACEUTICALS, INC.
    Inventors: Christos Kyratsous, William Olson, Peter Mason, Neil Stahl
  • Publication number: 20190367631
    Abstract: Provided herein are antibodies and antigen-binding fragments that bind MSR1 and methods of use thereof. According to certain embodiments, the antibodies bind human MSR1 with high affinity. In certain embodiments, the antibodies bind MSR1 without blocking, or blocking less than 90%, of modified LDL binding to MSR1. In some embodiments, the antibodies bind cell surface expressed-MSR1 and are internalized. The antibodies of the invention may be fully human antibodies. The invention includes anti-MSR1 antibodies, or antigen-binding fragments thereof, conjugated to drugs or therapeutic compounds.
    Type: Application
    Filed: May 8, 2019
    Publication date: December 5, 2019
    Inventors: Jesper Gromada, Viktoria Gusarova, Amy Han, Sokol Haxhinasto, Christos Kyratsous, Andrew J. Murphy, Thomas Nittoli, William Olson, Matthew Sleeman, Anna Zumsteg
  • Patent number: 10495152
    Abstract: A coupling assembly includes a body member and at least one end member attached to the body member. At least one connection arrangement is situated between the body member and the at least one end member, respectively. The at least one connection arrangement includes a plurality of bushings. A plurality of fasteners are each respectively received by the plurality of bushings to fasten the body member to the at least one end member. Each one of the plurality of bushings are rotationally fixed about their center longitudinal axes by the at least one connection arrangement.
    Type: Grant
    Filed: July 27, 2016
    Date of Patent: December 3, 2019
    Assignee: Phoenix Sokoh Couplings, LLC
    Inventors: Ryan Kenneth Marks, David William Olson
  • Patent number: 10488174
    Abstract: A voltage detection device for detecting proximity to an active alternating current (AC) voltage source is provided. The device includes a housing, at least one antenna configured to generate a signal in response to exposure to electromagnetic radiation, signal processing circuitry configured to process the signal generated by the at least one antenna, a processing device embedded in the housing and communicatively coupled to the signal processing circuitry, the processing device configured to determine, from the processed signal, whether the voltage detection device is proximate to the active AC voltage source, and an electronic switch embedded in the housing and one of included within the processing device and communicatively coupled to the processing device, the electronic switch configured to reduce an impact of interference on detection of the active AC voltage source.
    Type: Grant
    Filed: March 6, 2018
    Date of Patent: November 26, 2019
    Assignee: General Electric Company
    Inventors: Cheng-Po Chen, Christopher Bruce Gushee, Jose Luis Virgen, Emad Andarawis Andarawis, Glen William Brooksby, Jeffrey Ross Mayton, Nancy Cecelia Stoffel, Wyatt Beale Smith, Daniel Leroy Olson
  • Publication number: 20190350615
    Abstract: An ultrasonic surgical device is disclosed including a surgical tool including a proximal transducer mounting portion defining a surface, a distal end effector end, and a waveguide disposed therebetween, the waveguide extending along a longitudinal axis. The ultrasonic surgical device further includes a transducer is in mechanical communication with the surface of the transducer mounting portion. The transducer is configured to operate in a D31 mode with respect to the longitudinal axis of the waveguide.
    Type: Application
    Filed: July 31, 2019
    Publication date: November 21, 2019
    Inventors: Jeffrey D. Messerly, Brian D. Black, William A. Olson, Foster B. Stulen, Frederick Estera, William E. Clem, Jerome R. Morgan, Jeffrey L. Aldridge, Stephen M. Leuck, Kevin L. Houser
  • Patent number: 10463748
    Abstract: The present invention provides antibodies that bind to Staphylococcus aureus Hemolysin A toxin, and methods of use. According to certain embodiments of the invention, the antibodies are fully human antibodies that bind to Hemolysin A. The antibodies of the invention are useful for inhibiting or neutralizing Hemolysin A activity, thus providing a means of preventing or treating a Hemolysin A-related disease or disorder such as S. aureus infection. In some embodiments, the antibodies of the present invention are used in treating at least one symptom or complication of a S. aureus infection.
    Type: Grant
    Filed: January 2, 2018
    Date of Patent: November 5, 2019
    Assignee: Regeneron Pharmaceuticals, Inc.
    Inventors: Alida Coppi, Peter Mason, William Olson